Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Dysgeusia, Full blood count, Inappropriate schedule of product administration, Investigation, Laboratory test
Clinical narrative: 25 minutes later developed metallic/ink taste; 6th February 2021 for the first one and 23rd February 2021 for the second one; This is a spontaneous report from a contactable physician (patient). An 84-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Right on 23Feb2021 (Batch/Lot Number: EN6201; Expiration Date: 21Jun2021) (at the age of 84 years old) as 2ND DOSE, SINGLE DOSE for covid-19 immunisation. Medical history included ongoing asthma (Very occasionally), sleep apnoea from Apr2020 (use Cpap, use a breathing machine), arthritis, hypertension, benign prostatic hyperplasia, hypothyroidism. Patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on 06Feb2021 01:15 pm (Batch/Lot Number: EL9262) (at the age of 84 years old) for covid-19 immunisation. Concomitant medications included ramipril taken for hypertension, start and stop date were not reported; metoprolol taken for hypertension, start and stop date were not reported; tamsulosin hydrochloride (FLOMAX RELIEF) taken for benign prostatic hyperplasia, start and stop date were not reported; pregabalin taken for an unspecified indication, start and stop date were not reported; levothyroxine taken for hypothyroidism, start and stop date were not reported; rosuvastatin calcium (CRESTOR) taken for an unspecified indication, start and stop date were not reported; ezetimibe (ZETIA) taken for an unspecified indication, start and stop date were not reported; vitamin d nos taken for an unspecified indication, start and stop date were not reported; salbutamol (ALBUTEROL HFA) taken for asthma, start and stop date were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient developed a taste in mouth that was a cross between ink and metallic, mostly ink, that has persisted till the present time on 23Feb2021 01:45 AM (as reported). Physician stated, he received 2 Pfizer inoculations, one on February 6th and second on February 23rd. Within about 20-25 minutes of the time, in the second shot, he developed a taste in mouth that was a cross between ink and metallic, mostly ink, if you have ever touched your lips when you had, the regular ink that you drew up into a fountain pen and that has persisted till the present time. Physician stated, it tasted and thus tasted as ink. If he drinks plain drinking water, it taste like drinking ink. Physician stated, it came on within 20 minutes-25 minutes of the time that he received the vaccine. At first he thought it was the hand sanitizer in mouth but it never went away, so it may be a coincidence, it came on 20-25 minutes after and it never went away. His lab work was normal, all of it. He had a CBC, a complete chemistry, had a Fabre and a CRT, had a lipid exam and they were all absolutely normal, all on 26Feb2021 (as reported). No treatment was received for the event. The outcome of event metallic/ink taste was not recovered while for other event was unknown.  No follow-up attempts are needed. No further information is expected.